158 related articles for article (PubMed ID: 9326175)
1. Cellular effects of hydroxyurea in Hb SC disease.
Steinberg MH; Nagel RL; Brugnara C
Br J Haematol; 1997 Sep; 98(4):838-44. PubMed ID: 9326175
[TBL] [Abstract][Full Text] [Related]
2. Early detection of response to hydroxyurea therapy in patients with sickle cell anemia.
Ballas SK; McCarthy WF; Guo N; Brugnara C; Kling G; Bauserman RL; Waclawiw MA
Hemoglobin; 2010; 34(5):424-9. PubMed ID: 20854115
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
[TBL] [Abstract][Full Text] [Related]
4. The pharmacological manipulation of fetal haemoglobin: trials using hydroxyurea and recombinant human erythropoietin.
el-Hazmi MA; al-Momen A; Warsy AS; Kandaswamy S; Huraib S; Harakati M; al-Mohareb F
Acta Haematol; 1995; 93(2-4):57-61. PubMed ID: 7543719
[TBL] [Abstract][Full Text] [Related]
5. Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy.
Borba R; Lima CS; Grotto HZ
J Clin Lab Anal; 2003; 17(2):66-72. PubMed ID: 12640630
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea and erythropoietin therapy in sickle cell anemia.
Goldberg MA; Brugnara C; Dover GJ; Schapira L; Lacroix L; Bunn HF
Semin Oncol; 1992 Jun; 19(3 Suppl 9):74-81. PubMed ID: 1379376
[TBL] [Abstract][Full Text] [Related]
7. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea.
Veith R; Galanello R; Papayannopoulou T; Stamatoyannopoulos G
N Engl J Med; 1985 Dec; 313(25):1571-5. PubMed ID: 2415821
[TBL] [Abstract][Full Text] [Related]
9. Effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivo.
Ballas SK; Dover GJ; Charache S
Am J Hematol; 1989 Oct; 32(2):104-11. PubMed ID: 2757007
[TBL] [Abstract][Full Text] [Related]
10. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.
Brown AK; Sleeper LA; Miller ST; Pegelow CH; Gill FM; Waclawiw MA
Arch Pediatr Adolesc Med; 1994 Aug; 148(8):796-804. PubMed ID: 7519102
[TBL] [Abstract][Full Text] [Related]
11. Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia.
Orringer EP; Blythe DS; Johnson AE; Phillips G; Dover GJ; Parker JC
Blood; 1991 Jul; 78(1):212-6. PubMed ID: 1712641
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
Rodgers GP
Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
[TBL] [Abstract][Full Text] [Related]
13. Treatment of sickle cell anemia with hydroxyurea and erythropoietin.
Goldberg MA; Brugnara C; Dover GJ; Schapira L; Charache S; Bunn HF
N Engl J Med; 1990 Aug; 323(6):366-72. PubMed ID: 1695325
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric method for simultaneous assay of foetal haemoglobin containing red cells, reticulocytes and foetal haemoglobin containing reticulocytes.
Mundee Y; Bigelow NC; Davis BH; Porter JB
Clin Lab Haematol; 2001 Jun; 23(3):149-54. PubMed ID: 11553054
[TBL] [Abstract][Full Text] [Related]
15. Volume regulation and KCl cotransport in reticulocyte populations of sickle and normal red blood cells.
Quarmyne MO; Risinger M; Linkugel A; Frazier A; Joiner C
Blood Cells Mol Dis; 2011 Aug; 47(2):95-9. PubMed ID: 21576026
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production.
Dover GJ; Humphries RK; Moore JG; Ley TJ; Young NS; Charache S; Nienhuis AW
Blood; 1986 Mar; 67(3):735-8. PubMed ID: 2418898
[TBL] [Abstract][Full Text] [Related]
17. Enhancing Effect of Hydroxyurea on Hb F in Sickle Cell Disease: Ten-Year Egyptian Experience.
Youssry I; Abdel-Salam A; Ismail R; Bou-Fakhredin R; Mohamed Samy R; Ezz El-Deen F; Taher AT
Hemoglobin; 2017; 41(4-6):267-273. PubMed ID: 29251012
[TBL] [Abstract][Full Text] [Related]
18. Maximum urine concentrating ability in children with Hb SC disease: effects of hydroxyurea.
Iyer R; Baliga R; Nagel RL; Brugnara C; Kirchner K; Hogan S; Steinberg MH
Am J Hematol; 2000 May; 64(1):47-52. PubMed ID: 10815787
[TBL] [Abstract][Full Text] [Related]
19. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease.
Atweh GF; Sutton M; Nassif I; Boosalis V; Dover GJ; Wallenstein S; Wright E; McMahon L; Stamatoyannopoulos G; Faller DV; Perrine SP
Blood; 1999 Mar; 93(6):1790-7. PubMed ID: 10068649
[TBL] [Abstract][Full Text] [Related]
20. A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy.
Bridges KR; Barabino GD; Brugnara C; Cho MR; Christoph GW; Dover G; Ewenstein BM; Golan DE; Guttmann CR; Hofrichter J; Mulkern RV; Zhang B; Eaton WA
Blood; 1996 Dec; 88(12):4701-10. PubMed ID: 8977264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
